Both in Pharmaceuticals
Lifecore Biomedical vs Greenwich LifeSciences
Over the past year LFCR returned −10.0% and GLSI returned +106.5%; their daily moves had a correlation of 0.08.
LFCR −10.0% GLSI +106.5%Growth of $1, one year, split-adjusted
| Metric | LFCR | GLSI |
|---|---|---|
| Price | $6.40 | $17.41 |
| Market cap | $242.6M | $255.5M |
| Today | −1.84% | −8.37% |
| 1 month | −2.0% | +0.3% |
| 6 months | +21.7% | −26.5% |
| Year to date | −21.8% | −17.1% |
| 1 year | −9.3% | +90.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | 35.3% | — |
| Net margin | −20.9% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$136.9M | $8.9M |
| Dividend yield | — | — |
| Volatility (60d) | 98.4% | 92.1% |
| Short % of float | 6.5% | 24.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).